Asia-Pacific digital diabetes management market is expected to grow at a CAGR of 17.0% in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Market Segmentation
By Product & Services (Devices, Digital Diabetes Management Apps, Data Management Software and Platforms, Services), Type (Wearable Devices, Handheld Devices), End User (Home Care Settings, Diabetes Clinics, Academic & Research Institutes, Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2026.
Major growing sectors under the market segmentation are as follows:

> In product and services, devices are used mostly because of their high cost and use.

> In type, weight & diet management apps are the most rapidly growing segment because the digital diabetes management is mostly used by consumers.

> In end user, home care settings have a larger market than other applications because of the large number of digital diabetes management requirement in home care settings.

Key Market Players

The key market players for Asia-Pacific digital diabetes management market are listed below:

> Abbott
> PHC Holdings Corporation
> WellDoc, Inc.
> Sanofi
> Dexcom, Inc.
> DarioHealth
> Medtronic
> B. Braun Melsungen AG
> F. Hoffmann-La Roche Ltd
> Insulet Corporation
> Tandem Diabetes Care
> Lifescan, Inc.
> Agamatrix, Inc.
> Glooko, Inc.
> GlucoMe
> Becton Dickinson and Company
> Azumio
> Diabnext
> Voluntis